{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:55:54Z","timestamp":1773802554189,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hokuriku University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.neures.2010.12.009","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T09:54:44Z","timestamp":1293270884000},"page":"352-355","source":"Crossref","is-referenced-by-count":10,"title":["Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL\/6 mice"],"prefix":"10.1016","volume":"69","author":[{"given":"Akiko","family":"Muroyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Mitsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2010.12.009_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(90)90576-W","article-title":"Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism","volume":"515","author":"Arai","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neures.2010.12.009_bib0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neures.2010.12.009_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0922-4106(95)90083-7","article-title":"Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes","volume":"291","author":"Bougria","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neures.2010.12.009_bib0020","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2010.12.009_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-4547(20000101)59:1<126::AID-JNR15>3.0.CO;2-L","article-title":"Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL\/6 adult mouse: evidence of compensatory plasticity in nigrostriatal neurons","volume":"59","author":"Cochiolo","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neures.2010.12.009_bib0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2010.12.009_bib0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2010.12.009_bib0040","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein","volume":"96","author":"Galvin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2010.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neures.2010.12.009_bib0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neures.2010.12.009_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-4522(91)90180-V","article-title":"Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study","volume":"40","author":"Herkenham","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neures.2010.12.009_bib0060","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2010.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1460-9568.2006.04610.x","article-title":"1H MRS identifies lactate rise in the striatum of MPTP-treated C57BL\/6 mice","volume":"23","author":"Koga","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neures.2010.12.009_bib0070","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neures.2010.12.009_bib0075","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2010.12.009_bib0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/147323000903700221","article-title":"Axonal degeneration of nigra-striatum dopaminergic neurons induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"37","author":"Li","year":"2009","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.neures.2010.12.009_bib0085","doi-asserted-by":"crossref","first-page":"e1616","DOI":"10.1371\/journal.pone.0001616","article-title":"MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology","volume":"3","author":"Mallajosyula","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neures.2010.12.009_bib0090","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2010.12.009_bib0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2009.07.072","article-title":"Oral administration of coenzyme Q10 prevents cytochrome c release from mitochondria induced by 1-methyl-4-phenylpyridinium ion in mouse brain synaptosomes","volume":"463","author":"Mitsumoto","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2010.12.009_bib0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0006-291X(87)90346-9","article-title":"Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion","volume":"143","author":"Mizuno","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neures.2010.12.009_bib0105","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1073\/pnas.0611231104","article-title":"1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C","volume":"104","author":"Morfini","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2010.12.009_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/exnr.2002.8056","article-title":"1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum","volume":"179","author":"Nakai","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2010.12.009_bib0115","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.neures.2010.12.009_bib0120","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1068613","article-title":"Axonal self-destruction and neurodegeneration","volume":"296","author":"Raff","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neures.2010.12.009_bib0125","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2010.12.009_bib0130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/jcs.00967","article-title":"Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons","volume":"117","author":"Saha","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neures.2010.12.009_bib0135","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","article-title":"MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo","volume":"75","author":"Saporito","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2010.12.009_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0892-0362(02)00222-2","article-title":"MPTP: insights into parkinsonian neurodegeneration","volume":"24","author":"Speciale","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neures.2010.12.009_bib0145","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neures.2010.12.009_bib0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)91656-2","article-title":"Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL\/6 mice: a model for Parkinson's disease","volume":"528","author":"Sundstr\u00f6m","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neures.2010.12.009_bib0155","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2010.12.009_bib0160","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"98","author":"Vila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010210028786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010210028786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T08:03:08Z","timestamp":1637049788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010210028786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0168010210028786"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2010.12.009","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}